SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001640455-23-000036
Filing Date
2023-03-15
Accepted
2023-03-15 06:33:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A jnce031520238-k1.htm DEFA14A 33640
2 EX-99.1 a031520238-kexhibit991.htm EX-99.1 24875
  Complete submission text file 0001640455-23-000036.txt   59477
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37998 | Film No.: 23733230
SIC: 2836 Biological Products, (No Diagnostic Substances)